Submissions

Author Guidelines

The authors should submit papers for the journal Current Issues in Pharmacy and Medical Sciences via the internet platform: ( https://www.editorialsystem.com/cipms/ )

Current Issues in Pharmacy and Medical Sciences welcomes original research articles, review papers, short communications, and case reports. We encourage submissions from both academic researchers and clinical practitioners, highlighting translational approaches that bridge experimental results and real-world medical applications.

All submissions are initially evaluated by an editor to determine whether they fit the aims and scope of the journal. Manuscripts considered suitable are sent for peer review before a final decision on acceptance or rejection.

Before submission, authors are responsible for obtaining permission to publish any material included in the manuscript, such as images, documents, or datasets. All listed authors must consent to be identified as co-authors. Research involving humans or animals must be approved by an appropriate ethics committee in accordance with the legal requirements of the country where the study was conducted.

An editor may desk reject a submission if it does not meet minimum quality standards. Before submitting, ensure that:

• The study design and research argument are well-structured and clearly presented.
• The title is concise and informative.
• The abstract is self-contained and accurately reflects the content of the manuscript.

Following these recommendations increases the likelihood that reviewers will agree to evaluate the manuscript.

Anti-plagiarism check 

All submitted articles are checked using the Crossref Similarity Check system (iThenticate). Only articles with an overall similarity index below 30% and a detailed analysis that does not indicate unauthorized borrowing will be considered for publication.
Articles exceeding this threshold will be forwarded to the authors for their comment and possible corrections. In cases where corrections are not possible or the authors' position does not address the concerns, the articles will not be accepted for publication.
Authors' unjustified reuse of significant portions of their own, previously published texts (self-plagiarism) is also considered a violation of ethical principles and will result in the rejection of the article.

Scientific Quality and Relevance

The journal accepts only original manuscripts presenting current, well-designed, and scientifically sound research. Submissions should clearly state the research question, use appropriate methods, and provide reliable and up-to-date data. Manuscripts that do not meet these basic scientific standards may be rejected at the editorial screening stage.

Timeliness of the Editorial Process

To ensure efficient processing and timely publication:

• reviewers are expected to complete reviews within the set timeframe,
• authors must provide revisions or responses within the deadline specified by the editorial office,
• manuscripts not revised on time may be withdrawn.

These rules help maintain a smooth editorial workflow and improve publication quality.

Data Availability and Transparency

Authors should ensure transparency of their research. When possible, anonymized data, additional materials, or methodological details should be made available. A short Data Availability Statement is required at the end of the manuscript (e.g., “Data available on reasonable request”).

Author Contributions

For transparency, authors should briefly indicate their individual contributions (e.g., conceptualization, methodology, data analysis, writing). This helps ensure clarity and good scientific practice.

Reference Quality

Authors are encouraged to cite current, high-quality, peer-reviewed sources, preferably published within the last 5 years for fast-developing fields. Excessive self-citation should be avoided.

Language Quality

Manuscripts must be written in clear, correct English. Articles requiring substantial language improvement may be returned to authors before peer review.

Ethical Standards

• Articles must be original and not submitted elsewhere.
• Authors must disclose any conflicts of interest.
• Research involving humans or animals must have ethics committee approval.

Manuscript Structure

All manuscripts should be written in English and include the following sections:

1. Title – concise and descriptive.
2. Abstract –  should not exceed  to 250 words; summarize the aim, methodology, key results, and conclusions.
3. Keywords – 3–6 words, preferably aligned with MeSH terms.
4. Introduction – background, rationale, and objectives of the study.
5. Materials and Methods – detailed description of experimental design, materials, and analytical procedures.
6. Results – presentation of findings in text, tables, and figures.
7. Discussion – interpretation of results, comparison with existing literature, study limitations, and future perspectives.
8. Conclusions – brief summary of main findings.
9. Acknowledgements – optional; credit to individuals or institutions that contributed.
10. References – follow the journal’s citation style (APA recommended).

Tables and Figures

• Number all tables and figures consecutively and provide descriptive titles.
• Each table or figure should be understandable without referring to the text.
• Explain all abbreviations, symbols, and units in legends.
• Submit figures and tables in editable or high-resolution formats (e.g., Excel, Word, TIFF, JPEG).

Citations

• Literature must be prepared in Vancouver style.
• All cited sources must appear in the reference list.
• Prefer recent references (last 5 years) for fast-evolving topics.

ORCID

Authors submitting their manuscripts to Current Issues in Pharmacy and Medical Sciences are requested to enter their unique ORCID (Open Researcher and Contributor ID) number. ORCID is a unique digital identifier that makes it possible to distinguish between authors with the same surname and to correctly assign publications to individuals in scientific databases. You can obtain your ORCID number free of charge at: https://orcid.org.

Use of AI Tools

AI-based tools (e.g., ChatGPT, Copilot) may be used to support the writing process, but cannot replace the author’s personal input. Authors remain fully responsible for the accuracy, content, and references of the manuscript, as well as for any potential copyright issues.

• Transparency: If AI tools were used at any stage, authors must clearly disclose their usage, including tools and prompts employed.
• Permitted Use: AI may assist with text correction, content suggestions, or bibliography management.
• Disclosure Requirement: Simple spelling or grammar corrections do not require disclosure; extensive use (e.g., content generation) must be disclosed.
• Editorial Review: Each case of AI use is evaluated individually by the editorial board.

Payment

Publication requires a publication fee.

Once the manuscript is accepted, the author should pay 600 PLN (or 135 EUR) to the following bank account:

In PLN:

• Account number: 94 1020 3147 0000 8302 0084 6188
• Bank: PKO BP Oddział 1 w Lublinie
• SWIFT: BPKOPLPW

In EUR:

• Account number: PL50 1020 3147 0000 8202 0084 6253
• Bank: PKO BP S.A. O/Lublin
  ul. Watykańska 7
  20-538 Lublin

Payment Note: CIPMS, Surname and Name of the first author, ID of the submitted article.